These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9739894)

  • 1. [Known and potential risks related to the use of high dose intravenous immunoglobulins].
    Bussel A
    Ann Dermatol Venereol; 1997; 124(5):381-3. PubMed ID: 9739894
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute renal failure induced by intravenous immune globulin.
    Arunabh ; Arunabh S; Kumar G; Avila V
    Am Fam Physician; 1996 Feb; 53(3):862, 865. PubMed ID: 8594861
    [No Abstract]   [Full Text] [Related]  

  • 3. A recipient of immunoglobulin from a donor who developed vCJD.
    El-Shanawany T; Jolles S; Unsworth DJ; Williams P
    Vox Sang; 2009 Apr; 96(3):270. PubMed ID: 19522885
    [No Abstract]   [Full Text] [Related]  

  • 4. [Neurologic disorders caused by adverse effects of drugs--with special reference to iatrogenic nervous system diseases of the current interest].
    Kuzuhara S
    Nihon Naika Gakkai Zasshi; 1998 Sep; 87(9):1885-91. PubMed ID: 9816868
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute renal failure complicating high-dose intravenous immunoglobulin therapy for acquired haemophilia.
    McColl MD; Omran A; Walker ID; Lowe GD
    Haemophilia; 1999 Mar; 5(2):124-6. PubMed ID: 10215961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Important drug warning: Immune Globulin Intravenous (human) (IGIV) products.
    Epstein JS; Zoon KC
    Neonatal Netw; 2000 Mar; 19(2):60-2. PubMed ID: 11949001
    [No Abstract]   [Full Text] [Related]  

  • 7. [Intravenous administration of immunoglobulin--preparations and theoretical basis of their use].
    Jankowski A
    Postepy Hig Med Dosw; 2002; 56 Suppl():5-12. PubMed ID: 12661409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reemergence of sucrose nephropathy: acute renal failure caused by high-dose intravenous immune globulin therapy.
    Zhang R; Szerlip HM
    South Med J; 2000 Sep; 93(9):901-4. PubMed ID: 11005352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Onset of Creutzfeldt-Jakob disease mimicking an acute cerebrovascular event.
    Hohler AD; Flynn FG
    Neurology; 2006 Aug; 67(3):538-9. PubMed ID: 16894130
    [No Abstract]   [Full Text] [Related]  

  • 10. Renal toxicity of intravenous immunoglobulin.
    Kobosko J; Nicol P
    Clin Nephrol; 1992 Apr; 37(4):216-7. PubMed ID: 1582063
    [No Abstract]   [Full Text] [Related]  

  • 11. Intravenous gammglobulin-associated acute renal failure.
    Gupta N; Ahmed I; Nissel-Horowitz S; Patel D; Mehrotra B
    Am J Hematol; 2001 Feb; 66(2):151-2. PubMed ID: 11421298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Problems in the use of intravenously administered immunoglobulin].
    Martin TD
    Ter Arkh; 1996; 68(10):83-8. PubMed ID: 9026956
    [No Abstract]   [Full Text] [Related]  

  • 13. High-dose intravenous immunoglobulin therapy in dysimmune neuropathies.
    Nobile-Orazio E; Bersano A
    Neurol Sci; 2002 Apr; 23 Suppl 1():S25-32. PubMed ID: 12032584
    [No Abstract]   [Full Text] [Related]  

  • 14. Prion infections in Creutzfeldt-Jakob disease and its variants.
    Parker JC; Snyder JW
    Ann Clin Lab Sci; 1999; 29(2):112-7. PubMed ID: 10219698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential Creutzfeldt-Jakob disease (CJD) exposure: to notify or not to notify.
    Freedman J; Hall A; Dey A
    Transfus Sci; 1997 Sep; 18(3):491-2. PubMed ID: 10175161
    [No Abstract]   [Full Text] [Related]  

  • 16. [Iatrogenic Creutzfeld-Jakob disease. Significance of cases observed after extracted growth hormone treatment].
    Billette de Villemeur T
    Rev Neurol (Paris); 1998 Oct; 154(10):651-2. PubMed ID: 9846334
    [No Abstract]   [Full Text] [Related]  

  • 17. High-dose intravenous immune globulin for stiff-person syndrome.
    Solaro C
    N Engl J Med; 2002 May; 346(22):1747-8; author reply 1747-8. PubMed ID: 12041528
    [No Abstract]   [Full Text] [Related]  

  • 18. [Risk factors for sporadic Creutzfeldt-Jakob disease].
    Kittner C; Heinemann U; Zerr I
    Dtsch Med Wochenschr; 2009 Jul; 134(27):1429-35. PubMed ID: 19551608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology.
    Orange JS; Hossny EM; Weiler CR; Ballow M; Berger M; Bonilla FA; Buckley R; Chinen J; El-Gamal Y; Mazer BD; Nelson RP; Patel DD; Secord E; Sorensen RU; Wasserman RL; Cunningham-Rundles C;
    J Allergy Clin Immunol; 2006 Apr; 117(4 Suppl):S525-53. PubMed ID: 16580469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human--and porcine--dura mater linked to iatrogenic CJD.
    Smith M
    Tex Dent J; 2006 May; 123(5):449. PubMed ID: 16967693
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.